SENSEX    72488.99       -454.69    |    NIFTY    21995.85       -152.05 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Cipla in spotlight after getting approval for Sustiva
20-Jun-18   08:47 Hrs IST

Cipla announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Efavirenz Tablets 600mg from the United States Food and Drug Administration (US FDA). Cipla's Efavirenz Tablets 600mg is AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company's, Sustiva. It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. According to IQVIA (IMS Health), Sustiva and its generic equivalents had US sales of approximately $105 million for the 12-month period ended April 2018. The product is available for shipping immediately. The announcement was made after market hours yesterday, 19 June 2018.

Infosys announced that it has strengthened its footprint in France by establishing a Digital Center of Excellence in Marseille. The move is part of Infosys' efforts to bring its digital offerings to companies in France as they navigate the next stage in their business journey. In addition, the center will also deliver on a strategic seven-year partnership with CMA CGM Group the world leading container shipping organisation. This partnership was announced in September 2017 to simplify and transform the group's IT applications and improve customer service experience. The announcement was made after market hours yesterday, 19 June 2018.

Wheels India said that the board of directors of the company may consider issue of bonus shares in its board meeting scheduled to be held on 22 June 2018. The announcement was made after market hours yesterday, 19 June 2018.

Kansai Nerolac Paints said that the company has entered into Share Purchase Agreement (SPA) to acquire 55% of the paid-up equity share capital of RAK Paints, Bangladesh for a total consideration of Bangladeshi Taka (BDT) 57.26 crore (approximately Rs 45.81 crore). The announcement was made after market hours yesterday, 19 June 2018.

MPS through its wholly-owned subsidiary company, MPS Interactive Systems, has completed the acquisition of Tata Interactive Systems. MPS has now invested in the right issue of MPS Interactive Systems and has allotted equity and preference shares at par aggregating to Rs 43.99 crore. Post the allotment of shares, MPS Interactive Systems has now become wholly-owned material subsidiary of MPS. The announcement was made after market hours yesterday, 19 June 2018.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.85 88.79 1.06
United Kingdom (GBP) 1.17 1.00 103.96 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.80 83.59 1.00
Market News << ALL News
  18-Apr-2024, (03:39 )  HDFC Life gains afte..
  18-Apr-2024, (03:00 )  Sterlite Technologie..
  18-Apr-2024, (02:45 )  Krystal Integrated S..
  18-Apr-2024, (02:30 )  Volumes soar at Just..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)